Delivery Order SPE2DB22D3010-SPE2DB25FP3AE
- Not listed
- The Defense Logistics Agency awarded a $2,771.04 delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price delivery order with no set-aside designation, performing in Conshohocken, Pennsylvania, and scheduled for completion by October 14, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime...
- The Defense Logistics Agency awarded a Delivery Order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on July 24, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on November 4, 2025, with an ultimate completion date of November 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with performance in Conshohocken, Pennsylvania and completion by November 26, 2025. This is a firm fixed-price contract with no set-aside designation, awarded competitively on November 4, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg on June 20, 2025, with completion scheduled for July 14, 2025. This is a non-set-aside competitive award to the prime contractor's corporate office, with place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,771.04 by the Defense Logistics Agency for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract representing a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The company...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $33.25K delivery order by the Defense Logistics Agency (DLA) on September 24, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and active through December 2026....
- The Defense Logistics Agency awarded a $5.54K delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit doses) with a completion date of June 4, 2025. This is a firm fixed-price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99M...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Orgovyx 120 mg tablets in a quantity of 30-unit packages. This competitive, non-set-aside contract was awarded on April 21, 2025, with a ceiling value of $1,385.52 and an ultimate completion date of May 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3AEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,771.04 to supply Orgovyx 120 mg tablets (30-unit package) with delivery to AmerisourceBergen's Conshohocken, Pennsylvania facility. This firm fixed-price delivery order, issued on July 22, 2025, is non-set-aside and competitively awarded, with an ultimate completion date of August 12, 2025. The order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support to military and federal healthcare systems worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for the Defense Health Agency, U.S. Coast Guard, and military healthcare programs. As a primary vendor within the DLA's Medical Supply Chain, the company supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for Orgovyx, a prescription medication used in oncology treatment, exemplifies the company's role as a key supplier for specialized pharmaceutical commodities supporting federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/22/25 |